SEC Form 4 · accession 0001449374-17-000047
CAS MEDICAL SYSTEMS INC · CASM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Gamelin
Officer — Vice President, R&D
Period of report
Dec 21, 2017
Accepted (ET)
Dec 26, 2017 · 2:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000764579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 21, 2017 | A | 35,000 | $0.00 | A | 170,757 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $0.67 | Dec 21, 2017 | A | 20,000 | A | — | Dec 21, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Restricted stock grant vesting in four equal annual installments on 12/21/18, 12/21/19, 12/21/20 and 12/21/21.
- F2Stock option vesting in four equal annual installments on 12/21/18, 12/21/19, 12/21/20 and 12/21/21.